2022 the Japanese Society of Medical Oncology Annual Meeting

Session information

Mini-Oral Session

[MO4] Mini-Oral Session 4 Lung Cancer / Thoracic Cancer 2(Miscellaneous)
【E】

Thu. Feb 17, 2022 8:30 AM - 9:20 AM Room 6 (Room D, 1F, Kyoto International Conference Center)

Chair:Hiroyasu Kaneda(Department of Clinical Oncology, Osaka City University),Ikuo Sekine(Department of Medical Oncology, University of Tsukuba Faculty of Medicine)

Keunchil Park1, Joshua Sabari2, Eric B. Haura3, Catherine A. Shu4, Alexander Spira5, Ravi Salgia6, Karen L. Reckamp7, Rachel E. Sanborn8, Ramaswamy Govindan9, Joshua M. Bauml10, Joshua C. Curtin11, John Xie11, Amy Roshak11, Patricia Lorenzini11, Dawn Millington11, Meena Thayu11, Roland E. Knoblauch11, Byoung Chul Cho12 (1.Division of Hematology/Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 2.NYU School of Medicine, 3.H. Lee Moffitt Cancer Center & Research Institute, 4.Columbia University Medical Center, 5.Virginia Cancer Specialists Research Institute, US Oncology Research, 6.City of Hope, 7.Cedars-Sinai Medical Center, 8.Earle A. Chiles Research Institute, Providence Cancer Institute, 9.Washington University School of Medicine, 10.Perelman School of Medicine at the University of Pennsylvania, 11.Janssen R&D, LLC, 12.Yonsei Cancer Center, Yonsei University College of Medicine)

Takae Okuno1, Yutaka Fujiwara2,3, Makihara Reiko4, Hase Tetusnari5, Hashimoto Naozumi5, Kobayashi Misato1, Naito Tomoyuki3, Takahashi Toshiaki6, Kobayashi Haruki6, Shinnno Yuki7, Ikeda Takaya8,12, Goto Koichi8, Hosomi Yukio9, Watanabe Kageaki9, Kitazono Satoru10, Sakiyama Naomi4, Makino Yoshinori11, Yamamoto Noboru7 (1.Division of Medical Oncology & Respiratory Medicine, Shimane University Faculty of Medicine, 2.Department of Thoracic Oncology, Aichi Cancer Center, 3.Department of Respiratory Medicine, Mitsui Memorial Hospital, 4.Department of Pharmacy, National Cancer Center Hospital, 5.Department of Respiratory Medicine, Graduate School of Medicine, Nagoya University, 6.Division of Thoracic Oncology, Shizuoka Cancer Center, 7.Department of Thoracic Oncology, National Cancer Center Hospital, 8.Department of Thoracic Oncology, National Cancer Center Hospital East, 9.Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 10.Department of Thoracic Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 11.Department of Pharmacy, Department of Cancer Genome Medicine, Saitama Medical University International Medical Center., 12.Department of Respiratory Medicine, Nagasaki Kita Tokushukai Hospital)

Rui Kitadai1, Tetsuhiko Asao2, Takehito Shukuya2, Gaku Yamamoto3, Atsuto Mouri4, Ryosuke Imai5, Yoko Tsukita6, Kazutoshi Isobe7, Satoshi Watanabe8, Mitsuhiro Kamimura9, Ryo Morita10, Keita Kudo11, Minehiko Inomata12, Kazunari Tateishi13, Kazutaka Kakinuma14, Hiroshige Yoshioka15, Yukiko Namba16, Taku Nakagawa17, Kunihiko Kobayashi4, Kazuhisa Takahashi2 (1.Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan, 2.Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan, 3.Department of Respiratory Medicine, Hokkaido University Graduate School of Medicine, Hokkaido, Japan, 4.Department of Respiratory Medicine, Saitama Medical University International Medical Center, Saitama, Japan, 5.Department of Pulmonary Medicine, St. Luke’s International Hospital, Tokyo, Japan, 6.Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Miyagi, Japan, 7.Division of Respiratory Medicine, Toho University School of Medicine, Tokyo, Japan, 8.Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan, 9.Department of Pulmonology, National Hospital Organization Disaster Medical Center, Tokyo, Japan, 10.Department of Respiratory Medicine, Akita Kousei Medical Center, Akita, Japan, 11.Department of Thoracic Medical Oncology, National Hospital Organization Osaka Minami Medical Center, Osaka, Japan, 12.First Department of Internal Medicine, Toyama University Hospital, Toyama, Japan, 13.First Department of Internal Medicine, Shinshu University School of Medicine, Nagano, Japan, 14.Division of Respiratory Medicine, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan, 15.Department of Thoracic Oncology, Kansai Medical University Hospital, Osaka, Japan, 16.Department of Respiratory Medicine, Juntendo University Urayasu Hospital, Chiba, Japan, 17.Department of Thoracic Surgery, Omagari Kosei Medical Center, Akita, Japan)

Ryoko Higashiyama1, Tatsuya Yoshida1, Shigehiro Yagisita2, Naomi Sakiyama1, Ken Masuda1, Yuki Shinno1, Yuji Matsumoto1, Yusuke Okuma1, Yasushi Goto1, Hidehito Horinouchi1, Noboru Yamamoto1, Akinobu Hamada2, Yuichiro Ohe1 (1.Department of Thoracic Oncology, National Cancer Center Hospital, Japan, 2.Division of Molecular Pharmacology, National Cancer Center Research Institute, Japan)